Why Neoantigen-Based Immunotherapy is Emerging as the Fastest-Growing Segment in Oncology (2026–2034 Outlook)
The Neoantigens Market Forecast highlights a rapidly evolving segment of oncology focused on personalized cancer immunotherapy. Neoantigens are tumor-specific mutated peptides that arise from somatic mutations and are uniquely recognized by the immune system, making them highly attractive targets for precision oncology.  Market Overview and Research AccessThe Neoantigens Market Forecast...
0 Комментарии 0 Поделились